The potential of less radical surgery without parametrectomy. Are we safe?

Q3 Pharmacology, Toxicology and Pharmaceutics Journal of Experimental Therapeutics and Oncology Pub Date : 2018-11-01
Konstantinos Ntzeros, Nikolaos Thomakos, Ioannis Papapanagiotou, Alexandros Rodolakis
{"title":"The potential of less radical surgery without parametrectomy. Are we safe?","authors":"Konstantinos Ntzeros,&nbsp;Nikolaos Thomakos,&nbsp;Ioannis Papapanagiotou,&nbsp;Alexandros Rodolakis","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Aim: </strong>The aim of this study is to evaluate whether omission of parametrial removal in low risk patients with early stage cervical cancer is safe, taking into account the favorable prognostic characteristics that are usually used in recent studies debating a more conservative treatment in such patients.</p><p><strong>Methods: </strong>A comprehensive search conducted in PubMed and MEDLINE databases.</p><p><strong>Results: </strong>In low risk patients with favorable prognostic factors such as tumor size ≤2 cm, depth of stromal invasion ≤10 mm and no LVSI, there are 5% of patients having positive pelvic lymph nodes. Although parametrial involvement is associated with positive pelvic lymph node metastasis, there are studies which report patients with negative pelvic lymph node involvement with parametrial metastases. This indicates that although negative pelvic lymph nodes in low risk patients is a favorable criterion among of those previously reported for conservative treatment, does not eliminate the possibility of parametrial involvement.</p><p><strong>Conclusions: </strong>Although specific favorable prognostic characteristics may indicate less radical treatment for low risk patients with early stage cervical cancer, more research is needed to estimate the risk of parametrial involvement in low risk patients without pelvic node involvement.</p>","PeriodicalId":45335,"journal":{"name":"Journal of Experimental Therapeutics and Oncology","volume":"12 4","pages":"261-266"},"PeriodicalIF":0.0000,"publicationDate":"2018-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Experimental Therapeutics and Oncology","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0

Abstract

Aim: The aim of this study is to evaluate whether omission of parametrial removal in low risk patients with early stage cervical cancer is safe, taking into account the favorable prognostic characteristics that are usually used in recent studies debating a more conservative treatment in such patients.

Methods: A comprehensive search conducted in PubMed and MEDLINE databases.

Results: In low risk patients with favorable prognostic factors such as tumor size ≤2 cm, depth of stromal invasion ≤10 mm and no LVSI, there are 5% of patients having positive pelvic lymph nodes. Although parametrial involvement is associated with positive pelvic lymph node metastasis, there are studies which report patients with negative pelvic lymph node involvement with parametrial metastases. This indicates that although negative pelvic lymph nodes in low risk patients is a favorable criterion among of those previously reported for conservative treatment, does not eliminate the possibility of parametrial involvement.

Conclusions: Although specific favorable prognostic characteristics may indicate less radical treatment for low risk patients with early stage cervical cancer, more research is needed to estimate the risk of parametrial involvement in low risk patients without pelvic node involvement.

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
不切除参数的非根治性手术的潜力。我们安全吗?
目的:本研究的目的是评估低风险早期宫颈癌患者省略参数切除是否安全,考虑到近期研究中通常使用的有利预后特征,这些特征在这类患者中争论更保守的治疗。方法:在PubMed和MEDLINE数据库中进行综合检索。结果:在肿瘤大小≤2 cm、间质浸润深度≤10 mm、无LVSI等预后有利因素的低危患者中,有5%的患者盆腔淋巴结阳性。虽然参数淋巴结受累与盆腔淋巴结转移阳性相关,但也有研究报道盆腔淋巴结受累阴性的患者存在参数淋巴结转移。这表明,尽管在先前报道的保守治疗中,低风险患者盆腔淋巴结阴性是一个有利的标准,但并不能消除参数性受累的可能性。结论:尽管特定的良好预后特征可能表明低风险早期宫颈癌患者的根治性治疗较少,但需要更多的研究来评估无盆腔淋巴结累及的低风险患者的参数累及风险。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Giant Cervicodorsal Schwannoma. Clear cell variant of Oral Squamous cell carcinoma. Cervical carcinosarcoma presented in advanced stage after high grade cervical displasia. Glandular odontogenic cyst: a case report in an asymptomatic patient. Mebendazole in simultaneous combination with dexamethasone-(C21-phosphoramidate)-[anti-EGFR] generated utilizing a novel synthesis regimen: dual anti-neoplastic cytotoxicity against pulmonary adenocarcinoma (A549).
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1